Walters Inc. has been awarded the structural building contract for OmniaBio facility – located at McMaster Innovation Park, this manufacturing facility will be a commercial-scale cell and gene therapy facility operating as a contract development and manufacturing organization (CDMO). A CDMO works with other life sciences companies, large and small, to commercialize and manufacture their products. This arrangement allows life sciences companies to focus on research for new therapies and medical breakthroughs – and on growing their business. This new cell and gene therapy manufacturing facility will secure the future of life sciences jobs and innovation in Ontario while advancing pioneering medicine with the potential to cure many forms of cancer, cardiovascular disease, Parkinson’s disease and diabetes.

Walters will be responsible for fabricating and erecting the structural steel.

This ultra fast-track project is the first component of the master planned McMaster Innovation Park in Hamilton, Ontario, and will be delivered by an IPD Team comprised of Multiplex, Colliers Project Leaders, IBI Group, Arup Canada, McCallum Sather, Guild Electric Limited, Sprint Mechanical Inc., Flynn Canada and Walters Inc.

Read more

https://mcmasterinnovationpark.ca/blog/invests-in-state-of-the-art-cell-and-gene-therapy-facility-in-hamilton-to-take-life-sciences-sector-to-the-next-level

https://www.multiplex.global/news/multiplex-to-deliver-mcmaster-innovation-park-s-flagship-omniabio-b-canada-s-first-gene-therapy-facility/

To view McMaster Innovation Park project, please click HERE.